Postdoctoral fellow Corby Fink, PhD, works inside the Level 3 biocontainment lab as part of Western’s ImPaKT facility.

ImPaKT team expands COVID-19 research to target variants of concern

Posted on

As variants of concern continue to drive COVID-19 transmission around the globe, researchers at Western’s Imaging Pathogens for Knowledge Translation (ImPaKT) Facility are shifting their work toward understanding how to target them.

“The biggest concern is that the vaccines we are using right now might not provide full protection against current and future variants of concern,” said Eric Arts, PhD, professor and Canada research chair in HIV pathogenesis and viral control at Western’s Schulich School of Medicine & Dentistry. “If those start breaking through, we need to be prepared with new vaccine derivatives and therapeutics, and ensure that all the systems that we are using to protect people currently still work effectively against the variants….”

https://news.westernu.ca/2021/06/impakt-team-expands-covid-19-research-to-target-variants-of-concern/

Read More Impact Stories

Posted on
This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Posted on
A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Posted on
This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]